Related Experiment Video
Updated: Aug 13, 2026

Fabrication of High Contact-Density, Flat-Interface Nerve Electrodes for Recording and Stimulation Applications
Published on: October 4, 2016
Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan
Sayer I Al-Azzam1, Karem H Alzoubi1, Salah AbuRuz2
1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Insights
Drug-related problems (DRPs) are common in Jordanian hospital outpatient clinics, averaging 11.2 per patient. Clinical pharmacy services can help reduce these issues, especially in vulnerable patient groups.
Area of Science:
- Pharmacology and Clinical Pharmacy
- Health Services Research
Background:
- Drug-related problems (DRPs) significantly impact healthcare quality, costs, and patient outcomes.
- Optimizing drug therapy and preventing DRPs are crucial for improving patient care and reducing healthcare expenditure.
Purpose of the Study:
- To identify and characterize the types, numbers, and frequencies of DRPs in outpatient settings within Jordanian hospitals.
- To assess the association between DRPs and patient demographics or clinical conditions.
Main Methods:
- A prospective study involving 2,898 patients across cardiology, endocrine, and respiratory outpatient clinics in five Jordanian hospitals from September 2012 to December 2013.
- Clinical pharmacists assessed patients for DRPs using a validated pharmaceutical care manual.
- Data collected included patient demographics, clinical conditions, and identified DRPs.
Main Results:
- A total of 32,348 DRPs were identified, averaging 11.2 DRPs per patient.
- The most frequent DRPs involved the need for additional monitoring, issues with adherence to self-care or non-pharmacological therapy, and lack of patient understanding of non-pharmacological advice.
- Higher DRPs per patient were associated with older age, being unmarried, lower education levels, lack of health insurance, and specific conditions like hypertension, diabetes, and heart failure.
Conclusions:
- Clinical pharmacy services are a vital strategy for mitigating DRPs in outpatient settings.
- Specific patient populations, defined by age, socioeconomic factors, and comorbidities, are at higher risk for DRPs.
Abstract:
Optimization of drug therapy and preventing drug-related problems (DRPs) are major factors to improve health care, reduce expenditure, and potentially save lives. This study aimed at describing the types, numbers, and frequencies of DRPs in the outpatient settings of a group of hospitals in Jordan. The study was set in the cardiology, endocrine, and respiratory outpatient clinics of five major hospitals in Jordan. Patients who visited the above clinics during the period from September 2012 to December 2013, were candidates for this study. Each included subject was fully assessed for DRPs by clinical pharmacists according to a specially designed and validated pharmaceutical care manual. The main outcome measures were the number and types of DRPs. Data were collected from 2,898 patients (mean age ± standard deviation: 56.59±13.5 years). The total number of identified DRPs was 32,348, with an average of 11.2 DRPs per patient. The most common DRPs were a need for additional or more frequent monitoring, a problem in patients' adherence to self-care activities or nonpharmacological therapy, and that the patient was not given instruction in or did not understand nonpharmacological therapy or self-care advice. The numbers of DRPs per patient in our sample were associated with older age (>57 years), being unmarried, having an education level of high school or less, not having health insurance, and the presence of certain clinical conditions, including hypertension, diabetes mellitus, dyslipidemia, ischemic heart disease, cardiac catheterization, heart failure, and gout. In conclusion, implementation of clinical pharmacy services is a strategy to limit DRPs. Certain patient populations are more vulnerable to DRPs.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Dependence
Bioavailability Study Design: Healthy Subjects Versus Patients
Therapeutic Drug Monitoring: Affecting Factors
Drug Dosing: Geriatric Patients
Drug Toxicity: Risk factors

